AstraZeneca's Brilinta Approved With Aspirin Warning
Anti-platelet ticagrelor carries a boxed warning that concomitant aspirin dose must be limited to 100 mg/day, a departure for U.S. prescribers accustomed to high-dose aspirin therapy.
Anti-platelet ticagrelor carries a boxed warning that concomitant aspirin dose must be limited to 100 mg/day, a departure for U.S. prescribers accustomed to high-dose aspirin therapy.